Regulation of cyclo-oxygenase-2

Best Practice and Research: Clinical Gastroenterology

Volumn 15, Issue 5, 2001, Pages 787-800

  Stack, Elizabeth ^a   DuBois, Raymond N ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Arachidonic acid; Cyclo oxygenase; Eicosanoids; Prostaglandins

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CHLORIDE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P450; ICOSANOID; ISOENZYME; LIPOXYGENASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; RENIN;

ALZHEIMER DISEASE; ARACHIDONIC ACID METABOLISM; ARTHRITIS; ARTICLE; AUTOCRINE EFFECT; BONE METABOLISM; BONE REMODELING; BRAIN FUNCTION; CANCER RISK; CATALYSIS; CONTROLLED STUDY; DIGESTIVE SYSTEM INJURY; DRUG ACTIVITY; ENZYME REGULATION; HUMAN; ICOSANOID METABOLISM; INFLAMMATION; KIDNEY TUBULE ABSORPTION; MOUSE; NONHUMAN; PARACRINE SIGNALING; PROSTAGLANDIN SYNTHESIS; RAT; REPRODUCTION; SIGNAL TRANSDUCTION;

EID: 0034755476     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2001.0235     Document Type: Article

References (75)

1. Eicosanoids and the gastrointestinal tract
2. Introduction to eicosanoids and the gastrointestinal tract
3. Eicosanoids and the large intestine
4. The role of cyclooxygenase in inflammation, cancer, and development
5. Cyclooxygenase in biology and disease
6. COX-1 and COX-2 tissue expression: Implications and predictions
7. Clinical acute renal failure with nonsteroidal anti-inflammatory drugs
8. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis
9. Nitric oxide activates cyclooxygenase enzymes
10. Nitric oxide and the cyclooxygenase pathway
11. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
12. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs
13. The peroxisome proliferator-activated receptors: Ligands and activators
14. Effect of prostaglandin E2 on chloride transport across the rabbit thick ascending limb of Henle
15. Cellular distribution of prostanoid EP receptors mRNA in the rat gastrointestinal tract
16. A novel biological role for prostaglandin D2 is suggested by distribution studies of the rat DP prostanoid receptor
17. Renal prostanoid receptors
18. Prostaglandin synthase 2
19. Cyclooxygenase-2 is associated with the macula densa in rat kidney and increases with salt restriction
20. Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells
21. The macula densa: Recent developments
22. Effect of prostaglandin E2 on chloride transport across the rabbit thick ascending limb of Henle
23. Functional and molecular aspects of renal prostaglandin receptors
24. The role of prostaglandins in labor and delivery
25. Inhibition of human premature labor by indomethacin
26. Hormonal control of gene expression in the ovary
27. Failure of parturition in mice lacking the prostaglandin F receptor
28. The role of prostaglandins in the regulation of bone metabolism
29. Anabolic effects of prostaglandins in cultured fetal rat calvariae: Structure-activity relations and signal transduction pathway
30. Pulsating fluid flow stimulates prostaglandin release and inducible prostaglandin G/H synthase mRNA expression in primary mouse bone cells
31. Differential effects of nonsteroidal anti-inflammatory drugs on constitutive and inducible prostaglandin G/H synthase in cultured bone cells
32. Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6 induced osteoclast formation
33. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts
34. Involvement of cyclooxygenase-2 in LPS-induced fever and regulation of its mRNA by LPS in the rat brain
35. Inhibition of brain cyclooxygenase-2 activity and the antipyretic action of nimesulide
36. Induction of cyclooxygenase-2 in the brain by cytokines
37. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids
38. Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: Implications for Alzheimer's disease
39. Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2
40. Risk of Alzheimer's disease and duration of NSAID use
41. Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: A current appraisal
42. Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging
43. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis
44. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage: Influence of nitric oxide
45. Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis
46. Nitric oxide enhances cyclooxygenase activity in articular cartilage
47. NSAID gastropathy. A new understanding
48. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1
49. Role of intestinal epithelial cells in the host secretary response to infection by invasive bacteria: Bacterial entry induces epithelial prostaglandin H synthase-2 expression and prostaglandin E2 and F2α production
50. Biologic effects of nonsteroidal anti-inflammatory drugs
51. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
52. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II
53. Prostaglandin synthase-2 gene disruption causes severe renal pathology in the mouse
54. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals
55. Aspirin and the risk of colorectal cancer in women
56. Colorectal cancer and nonsteroidal anti-inflammatory drugs
57. Aspirin use and reduced risk of fatal colon cancer
58. Aspirin use and risk of fatal cancer
59. The role of nonsteroidal antiinflammatory drugs in colorectal cancer prevention
60. Aspirin use and potential mechanisms for colorectal cancer prevention
61. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
62. Prostaglandin H synthase-2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect
63. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
64. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
65. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
66. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2
67. Modulation of apoptosis by prostaglandin treatment in human colon cancer cells
68. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2
69. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
70. δ716 knockout mice by inhibition of prostaglandin endoperoxide synthase-2 (COX-2)
71. PPAR-δ is an APC regulated target of nonsteroidal anti-inflammatory drugs
72. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
73. Sulfone metabolite of sulindac inhibits mammary carcinogenesis
74. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway